DC
FOLD

Deere & Company’s Amicus Therapeutics FOLD Stock Holding History

Deere & Company’s Portfolio FOLD Stock Details FOLD Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2015
Q4 		– Sell
-36,307
Closed -$508K – 953
2015
Q3 		$508K Sell
36,307
-12,713
-26% -$199K 0.03% 538
2015
Q2 		$694K Hold
49,020
– – 0.04% 509
2015
Q1 		$533K Sell
49,020
-18,732
-28% -$165K 0.03% 602
2014
Q4 		$564K Sell
67,752
-32,420
-32% -$223K 0.03% 550
2014
Q3 		$596K Buy
+100,172
New +$525K 0.03% 538

Other funds holding FOLD

Fidelity Investments
Fidelity Investments Boston, Massachusetts $1.9T AUM 41.92% 1-Year Est. Return
PA
Perceptive Advisors New York $5.12B AUM 314.02% 1-Year Est. Return
RG
Redmile Group San Francisco, California $1.51B AUM 164.17% 1-Year Est. Return
SAM
Sectoral Asset Management Montreal, Quebec, Canada $121M AUM 73.47% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
T. Rowe Price Associates
T. Rowe Price Associates Baltimore, Maryland $865B AUM 30.76% 1-Year Est. Return
BFA
BlackRock Fund Advisors San Francisco, California $542B AUM 18.13% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return
JHIU
Janus Henderson Investors US Denver, Colorado $122B AUM 18.26% 1-Year Est. Return
Jennison Associates
Jennison Associates New York $145B AUM 34.61% 1-Year Est. Return

Deere & Company's FOLD Position: Q4 2015 in Review

Deere & Company sold out of Amicus Therapeutics (FOLD) in Q4 2015, closing a stake of 36,307 shares — an estimated $508K sold.

Deere & Company first reported a position in FOLD in Q3 2014 and held it in 5 quarters. The position peaked at $694K in Q2 2015. 139 funds tracked by Wall St. Rank hold FOLD as of Q4 2015.

  • Deere & Company reported no remaining Amicus Therapeutics position as of Q4 2015 after selling out during the quarter.
  • Deere & Company sold 36,307 Amicus Therapeutics shares in Q4 2015, an estimated $508K.
  • Deere & Company first reported a position in Amicus Therapeutics in Q3 2014 and held it in 5 quarters.
  • Deere & Company's Amicus Therapeutics position peaked at $694K in Q2 2015.
  • 139 funds tracked by Wall St. Rank held Amicus Therapeutics as of Q4 2015.

Based on Deere & Company's 13F filing for Q4 2015, filed 10 Feb 2016.